We are live on
!
Find out more
CNHF
Conrad N. Hilton Foundation Portfolio holdings
AUM
$228M
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+26.89%
1 Year Est. Return
+15.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.85M
AUM Growth
-$72.2M
(-90%)
Cap. Flow
-$71.7M
Cap. Flow
% of AUM
-913.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$8.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$49.9M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$25M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$5.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
FPN
AFO
APSI
HFA
CI
BWA
GCM
CM
Conrad N. Hilton Foundation's Q4 2020 Portfolio in Review
As of Q4 2020, Conrad N. Hilton Foundation held 4 positions worth $7.85M, down 90% from $80M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Conrad N. Hilton Foundation withdrew a net $71.7M in Q4 2020, closing 3 positions. Its most notable exit was iShares Core MSCI EAFE ETF, an estimated $49.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
Against the trend, Conrad N. Hilton Foundation opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $7.85M.
- Conrad N. Hilton Foundation's largest Q4 2020 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 63,481 shares worth $7.85M.
- Conrad N. Hilton Foundation fully exited iShares Core MSCI EAFE ETF in Q4 2020, selling an estimated $49.9M.
- Conrad N. Hilton Foundation's ten largest holdings make up 100% of its $7.85M portfolio in Q4 2020.
- Conrad N. Hilton Foundation opened 1 new position and closed 3 in Q4 2020.
- Conrad N. Hilton Foundation's portfolio value fell 90% quarter-over-quarter to $7.85M.
Based on Conrad N. Hilton Foundation's 13F filing for Q4 2020, filed 16 Feb 2021.